Cargando…
Mechanisms of Cell Killing Response from Low Linear Energy Transfer (LET) Radiation Originating from (177)Lu Radioimmunotherapy Targeting Disseminated Intraperitoneal Tumor Xenografts
Radiolabeled antibodies (mAbs) provide efficient tools for cancer therapy. The combination of low energy β(−)-emissions (500 keV(max); 130 keV(ave)) along with a γ-emission for imaging makes (177)Lu (T(1/2) = 6.7 day) a suitable radionuclide for radioimmunotherapy (RIT) of tumor burdens possibly too...
Autores principales: | Yong, Kwon Joong, Milenic, Diane E., Baidoo, Kwamena E., Brechbiel, Martin W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4881558/ https://www.ncbi.nlm.nih.gov/pubmed/27196891 http://dx.doi.org/10.3390/ijms17050736 |
Ejemplares similares
-
Pre-Clinical Assessment of (177)Lu-Labeled Trastuzumab Targeting HER2 for Treatment and Management of Cancer Patients with Disseminated Intraperitoneal Disease
por: Ray, Geoffrey L., et al.
Publicado: (2011) -
Cell Killing Mechanisms and Impact on Gene Expression by Gemcitabine and (212)Pb-Trastuzumab Treatment in a Disseminated i.p. Tumor Model
por: Yong, Kwon Joong, et al.
Publicado: (2016) -
Targeted α-Particle Radiation Therapy of HER1-Positive Disseminated Intraperitoneal Disease: An Investigation of the Human Anti-EGFR Monoclonal Antibody, Panitumumab
por: Milenic, Diane E., et al.
Publicado: (2017) -
(212)Pb-radioimmunotherapy potentiates paclitaxel-induced cell killing efficacy by perturbing the mitotic spindle checkpoint
por: Yong, K J, et al.
Publicado: (2013) -
Impact of α-Targeted Radiation Therapy on Gene Expression in a Pre-Clinical Model for Disseminated Peritoneal Disease when Combined with Paclitaxel
por: Yong, Kwon Joong, et al.
Publicado: (2014)